Winston Francois builds podcast and audio programs that survive MLR review, keep branded and unbranded content properly separated, and reach HCPs and patients through the right channel with the right disclosures. We embed as your fractional audio marketing team, not an agency handing you a microphone and a release form.
The Problem
MLR Review Was Built for a Static Asset, Not a Conversation
Medical, Legal, and Regulatory review workflows assume a fixed piece of copy that gets redlined, revised, and locked before it ships. A podcast interview does not work that way. The moment a host asks a follow-up question that was not in the pre-approved script, the conversation drifts into territory nobody cleared, and there is no clean way to redline eleven minutes of spontaneous back-and-forth the way you would a print ad.
Fair Balance Does Not Fit Naturally Into a Conversational Format
Any mention of a branded product on air triggers a fair balance obligation, meaning the risks have to appear alongside the benefits, not buried in show notes nobody reads. Reading a full safety statement into a podcast interview breaks the conversational tone that makes audio work as a format in the first place, and cutting corners on it is a promotional compliance violation, not a stylistic misstep.
Branded and Unbranded Content Keep Bleeding Into the Same Feed
Disease-awareness audio content and branded product content are governed by different rules, and once they sit on the same podcast feed with the same host and the same intro music, a reviewer can reasonably treat the whole feed as promotional. Marketing teams that want a disease-education show and a product-focused show frequently build one podcast to save budget, then discover mid-flight that the mixed content forces every unbranded episode through the same heavy review process as the branded ones.
HCP Audiences and Patient Audiences Need Two Different Shows, Not One Adjusted Script
A medical education podcast aimed at prescribers needs clinical depth, data citations, and often CME accreditation through a recognized provider, while a patient or caregiver show needs plain-language framing and DTC-level disclosure standards. Companies frequently try to serve both audiences from a single feed by simplifying the language in some episodes, which under-serves the HCP listener and still fails the regulatory bar for patient-facing content.
Guest Vetting Is the Off-Label Risk Nobody Budgets For
Inviting a physician, KOL, or researcher onto a podcast means inviting someone with their own clinical opinions, and those opinions do not stop at the edge of the approved label. A treating physician describing how they actually use a therapy in practice can casually reference an off-label use, a head-to-head comparison, or an efficacy claim that was never studied, and once that is recorded and published it is out in a format the FDA treats the same as any other promotional statement.
You Cannot Un-Publish an Episode the Way You Can Pull a Web Page
A podcast episode gets syndicated to Apple Podcasts, Spotify, Overcast, and a dozen smaller aggregators within hours of publishing, and pulling it from your own RSS feed does not remove the copies already cached and indexed across those platforms. When a compliance issue surfaces after an episode goes live, there is no single edit-and-republish fix the way there is for a landing page or blog post.
How We Help
We start with a two-week audit of your current audio footprint and the review process behind it, if either exists yet.
From the audit we build a structure, not a style guide. That starts with separating branded and unbranded programming into distinct feeds with distinct hosts and distinct intros, so a disease-awareness episode never has to carry the review burden of a branded one.
Then we build the production workflow that makes MLR review realistic instead of theoretical.
We build the review calendar around how podcasts actually get made, not how a print campaign gets made.
On the guest side, we build a standing vetting process: a short compliance questionnaire before booking, a review of the guest's public statements and publications for anything that conflicts with the approved label, and a signed understanding of what topics are off-limits for that specific episode.
We handle distribution the same way we handle content: HCP-facing shows go through channels built for that audience, patient and caregiver shows go through consumer podcast platforms with the disclosure language that format requires, and we do not treat total downloads as a substitute for knowing who actually listened.
We work fractional and embedded, not project-and-disappear. The person who wrote your guest briefing template is the same person MLR calls when a question comes up about episode 14, three weeks after it published.
What we deliver
- Audio and podcast compliance audit covering existing episodes, MLR workflow, and branded/unbranded separation
- Separate feed architecture for branded, unbranded, HCP-facing, and patient-facing audio content
- Guest vetting process, including compliance questionnaire and pre-interview briefing template
- Scripted fair balance language built for a conversational format, timed and pre-approved
- MLR review calendar aligned to podcast production stages (brief, rough cut, final mix)
- Distribution plan matched to audience: HCP channels for medical education content, consumer platforms for patient content
- Documented review trail per episode for audit readiness and post-publish issue response
The biggest audio compliance risk is never the script you wrote and had approved. It's the eight unscripted minutes of guest Q&A at the end that nobody thought to route through MLR before the episode went to the feed.
Our Methodology
We run in 90-day sprints because that is enough time to stand up a real production and review system, and short enough that the plan never outlives its assumptions. Days 1-15 are audit: every existing episode, the current MLR workflow, and whether branded and unbranded content are already mixed on one feed. Days 16-45 are build: feed architecture, guest vetting materials, fair balance scripting, and a review calendar that MLR and production both sign off on. Days 46-75 are live production against that system, recording and releasing real episodes with the review trail running the whole time. Days 76-90 are handoff and a documented process for the next quarter of episodes, including what happens if a compliance issue surfaces post-publish.
This differs from a traditional podcast production agency in one specific way: we do not hand you a show format and a release calendar and walk away. We sit in the pre-interview briefing calls, we write the fair balance script, and we stay on when MLR has a question about an episode that already aired, because a review process nobody actually uses when the pressure is on is worse than no review process at all.
How We Work
The first 30 days are diagnostic. We listen to what you have published, sit with MLR and your marketing team to map the actual review gaps, and come back with a feed architecture and production workflow built for your specific mix of HCP and patient audiences, not a generic podcast launch plan.
Days 31-60 are build and first production. We write guest briefing templates, build the fair balance script library, and set the MLR review calendar against your real release cadence. We are in the room for guest bookings and pre-interview calls, not reviewing a transcript after the fact.
By day 90 you have a recurring show, or a set of shows, running on a review process your MLR team actually trusts. From there we typically stay on as a fractional production and compliance team, cadence set by your release schedule, weekly during active recording periods and lighter once the workflow is running on its own.
If your biotech or pharma company needs a podcast or audio program that can actually clear review, we should talk.
- Episodes that clear MLR review without last-minute rewrites or delayed release dates
- Clean separation between branded and unbranded audio content across distinct feeds
- Guest interviews with off-label risk caught before recording, not after publishing
- Fair balance language that reads naturally instead of like an inserted disclaimer
- Distribution matched to the right audience: HCP channels versus consumer podcast platforms
- A documented review trail per episode that holds up if a compliance question comes up later
If your biotech & pharma company needs podcast & audio marketing leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
How do you handle MLR review for a podcast that includes unscripted interview segments?
We build a pre-interview briefing process so MLR reviews the guest talking points and boundaries before recording, not a rough transcript after the fact. The host is trained to redirect any answer that strays into off-label or comparative claim territory, and any branded mention gets a pre-scripted, pre-approved fair balance read.
What is the difference between a branded and an unbranded podcast, and why does it matter?
An unbranded, or disease-awareness, episode discusses a condition without naming or promoting a specific product, while a branded episode includes product mentions and carries the fair balance and promotional review obligations that come with that. Mixing both on one feed with the same host and branding risks having the entire feed treated as promotional content by reviewers, which slows down every episode, including the ones that should have been simple.
How do you vet a physician or KOL guest before they appear on the show?
Every guest goes through a short compliance questionnaire and a pre-interview briefing call where we walk through what topics are on and off the table for that specific episode, based on the approved label and the show's branded or unbranded status. We also review the guest's recent public statements and publications for anything that conflicts with what we are cleared to discuss.
Can one podcast reach both HCPs and patients, or do we need separate shows?
In almost every case you need separate shows. HCP-facing medical education audio needs clinical depth, data citations, and often CME accreditation, while patient and caregiver content needs plain-language framing and different disclosure requirements.
What happens if a compliance issue is found in an episode after it has already published?
We keep a documented review trail per episode, so if a question comes up post-publish we can show exactly what was approved, when, and by whom. Because a podcast episode syndicates across multiple platforms within hours, pulling it from your own feed does not remove every cached copy, so the response plan focuses on correction and, where needed, a follow-up episode or clarifying note rather than assuming a takedown solves it.
What does a podcast and audio marketing engagement cost?
Engagements are scoped fractional, typically in the range of $12K-$30K per month depending on release cadence, whether you need separate HCP and patient shows, and how much guest booking and vetting work is involved. That covers the embedded production and compliance team, not a fixed number of episodes, because the highest-value work in the first 90 days is building the review workflow itself.
How long before we can launch our first compliant episode?
Most teams are ready to record within 30 to 45 days once the feed architecture, guest briefing templates, and MLR review calendar are in place. The first episode usually takes longer than the ones that follow because the review process is new to everyone involved; by the fourth or fifth episode the turnaround from booking to release settles into a predictable rhythm.
